{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "33957360",
  "DateCompleted": {
    "Year": "2021",
    "Month": "07",
    "Day": "05"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "07",
    "Day": "05"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "04",
        "Day": "27"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.jad.2021.04.024",
      "S0165-0327(21)00348-7"
    ],
    "Journal": {
      "ISSN": "1573-2517",
      "JournalIssue": {
        "Volume": "289",
        "PubDate": {
          "Year": "2021",
          "Month": "Jun",
          "Day": "15"
        }
      },
      "Title": "Journal of affective disorders",
      "ISOAbbreviation": "J Affect Disord"
    },
    "ArticleTitle": "Letter to the Editor: Comparative efficacy of racemic ketamine and esketamine for depression: A systematic review and meta-analysis.",
    "Pagination": {
      "StartPage": "88",
      "EndPage": "89",
      "MedlinePgn": "88-89"
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Psychiatry, Faculty of Clinical Sciences, University of Lund, Sweden. Electronic address: Joakim.ekstrand@med.lu.se."
          }
        ],
        "LastName": "Ekstrand",
        "ForeName": "Joakim",
        "Initials": "J"
      }
    ],
    "PublicationTypeList": [
      "Letter",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "J Affect Disord",
    "NlmUniqueID": "7906073",
    "ISSNLinking": "0165-0327"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "50LFG02TXD",
      "NameOfSubstance": "Esketamine"
    },
    {
      "RegistryNumber": "690G0D6V8H",
      "NameOfSubstance": "Ketamine"
    }
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "J Affect Disord. 2021 Jan 1;278:542-555",
      "PMID": "33022440"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Depression"
    },
    {
      "QualifierName": [
        "drug therapy"
      ],
      "DescriptorName": "Depressive Disorder, Major"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Depressive Disorder, Treatment-Resistant"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Ketamine"
    }
  ]
}